Armata Pharmaceuticals, Inc. — Director's Dealing 2019

May 24, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Armata Pharmaceuticals, Inc. (ARMP)
CIK: 0000921114
Period of Report: 2019-05-22

Reporting Person: Martin Steven Robert (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-22	Stock Option (Right to Buy)	$3.15	A	149362	Acquired	2029-05-22	Common Stock (149362)	Direct

Footnotes

F1: The stock option vests as to twenty-five percent (25%) of the underlying shares of common stock on each annual anniversary of the date of grant.